← Insider buys
AGLE

Aeglea Biotherapeutics, Inc.

President and CEO Anthony G. Quinn bought $784K of Aeglea Biotherapeutics, Inc.

Bought$783,750
$4.75Price
165,000Shares
+44%Stake

What AGLE did for a copier

Prices for AGLE after this filing aren't in yet.

Anthony G. Quinn's record

9 other buys on record. A record shows here once 3 of them have 3 months of prices.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Thu, Apr 30. Filed Mon, May 4, 3:30 AM ET, before the open. Not investment advice.